The Pennant Group (NASDAQ:PNTG – Get Free Report) will be posting its quarterly earnings results after the market closes on Monday, May 6th. Analysts expect The Pennant Group to post earnings of $0.15 per share for the quarter. The Pennant Group has set its FY 2024 guidance at 0.820-0.910 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.
The Pennant Group (NASDAQ:PNTG – Get Free Report) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.01). The firm had revenue of $145.95 million for the quarter, compared to the consensus estimate of $136.79 million. The Pennant Group had a net margin of 2.46% and a return on equity of 12.78%. During the same period last year, the company posted $0.15 EPS. On average, analysts expect The Pennant Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
The Pennant Group Stock Performance
Shares of PNTG opened at $21.40 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $642.21 million, a P/E ratio of 48.64, a price-to-earnings-growth ratio of 2.24 and a beta of 2.01. The firm’s fifty day simple moving average is $19.60 and its two-hundred day simple moving average is $15.89. The Pennant Group has a 12 month low of $10.31 and a 12 month high of $21.81.
Wall Street Analyst Weigh In
View Our Latest Report on PNTG
About The Pennant Group
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Featured Stories
- Five stocks we like better than The Pennant Group
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Why Invest in 5G? How to Invest in 5G Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- What is the S&P 500 and How It is Distinct from Other Indexes
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.